 |
"The idea is to pro-vide a meeting point in an attractive location"
|
This month’s columnist: Ylva Williams, new CEO of Stockholm Science City Foundation
How would you describe the development of the life science cluster in the Karolinska/Norra Station area? The largest infrastructure project in Stockholm since the underground was built? A project equal to building 15 Colosseums in Rome? Or 24 Hötorgshus buildings in Stockholm? Being CEO of Stockholm Science City Foundation, with a mission to attract businesses and researchers to the area, is truly a dream job.
Emerging between the cities of Stockholm and Solna is the modern life science city of the primary life science cluster in Scandinavia, Stockholm - Uppsala. Based on life science research at the three major universities in Stockholm: Karolinska Institutet (KI), KTH Royal Institute of Technology and Stockholm University, and in our neighbouring city Uppsala, Uppsala University, this city section is strategically positioned near central Stockholm – The Capital of Scandinavia. Situated in a region that is home to 500 of Sweden's 800 life science companies and a global pharmaceutical company, the site will house the future New Karolinska Solna University Hospital (NKS), and the national Science for Life Laboratory (SciLifeLab), due to open in January 2010. SciLifeLab, a joint initiative from the three Stockholm universities who are discussing a partnership with Uppsala University, will conduct research in six key areas to achieve rapid progress in biotechnology. This is an important step in the fight against major diseases such as cancer, diabetes and cardiovascular disease.
The sheer size of this project, which includes the construction of roads, hotels, office and laboratory spaces, and the development of the Eastern section of the hospital and the KI campus, represents a total investment cost of around EUR 5 billion!
By mixing research, business and clinical care we will create a favourable environment for closer interaction between the players. Closer interaction facilitates knowledge and information exchange and will foster business development and growth, giving the companies a competitive advantage on the global stage. The idea is to provide a meeting point in an attractive location where translational research and development can flourish. What we offer when you establish a business in Karolinska/Norra Station will provide unique means to interact with world leading research and healthcare facilities.
The life science industry not only accounts for a large proportion of Swedish exports, but it also strives to improve human health. It is an industry that affects us all. Regardless of age, background and mission in life.
The challenge for my colleagues and for me is that all the stakeholders have very different perspectives! But the joy we get from seeing the parties coming together and cooperating so well, more than makes up for all the bumps along the way.